Skip to main content

Table 2 Hazard ratios comparing risks of death and ≥ 1 severe exacerbation among the different states based on the best fitting Weibull multi-state Markov model without adjustment for covariates (mITT population)

From: Relationship between risk, cumulative burden of exacerbations and mortality in patients with COPD: modelling analysis using data from the ETHOS study

Transition to death from

vs transition to death from

HR

SE

95% CI

State 2 (1 moderate exacerbation)

State 1 (No exacerbation)

1.8

0.3

(1.1–2.9)

State 3 (≥ 2 moderate exacerbations)

State 1 (No exacerbation)

2.1

0.3

(1.1–3.9)

State 3 (≥ 2 moderate exacerbations)

State 2 (1 moderate exacerbation)

1.2

0.4

(0.6–2.4)

State 4 (≥ 1 severe exacerbations)

State 1 (No exacerbation)

11.4

0.2

(7.7–17.0)

State 4 (≥ 1 severe exacerbations)

State 2 (1 moderate exacerbation)

6.4

0.3

(3.8–10.8)

State 4 (≥ 1 severe exacerbations)

State 3 (≥ 2 moderate exacerbations)

5.4

0.3

(2.9–10.3)

Transition to ≥ 1 severe exacerbation from

vs transition to ≥ 1 severe exacerbation from

   

State 2 (1 moderate exacerbation)

State 1 (No exacerbation)

1.4

0.1

(1.2–1.6)

State 3 (≥ 2 moderate exacerbations)

State 1 (No exacerbation)

1.9

0.1

(1.6–2.3)

State 3 (≥ 2 moderate exacerbations)

State 2 (1 moderate exacerbation)

1.4

0.1

(1.1–1.7)

  1. HR Hazard ratio, CI Confidence interval, mITT Modified intent-to-treat, SE Standard error for the log hazard ratio
  2. Markov assumption: transition to future states depends only on the current state at time t and not previously occupied states